Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
60
days
A contract research organization perspective on secondary pharmacology: current practices, panel selection, and emerging needs for interpretation
Authors
Emilie Desfosses; Stéphanie A.D. Bonnet; Thierry JolasShow moreShow less
Affiliations
Eurofins Discovery, 2 rue du Professeur Gargouïl, BP30001, 86600 Celle-Lévescault, FranceShow moreShow less
48
days
Integration of safety pharmacology endpoints into toxicology studies - A survey of GLP institutions in China
Authors
Bin Zhao; Chen Wang; Na Zhang; Ailing Zeng; Yaqin Peng; Wenqiang Zhang; Xuewu Liu; Jean-Pierre Valentin; Jennifer Pierson; Michael K. Pugsley; Jufeng WangShow moreShow less
Affiliations
West China-Frontier PharmaTech Co., Ltd., Chengdu, China; Triapex Laboratory Co., Ltd., Nanjing, China; Pharmaron Beijing Co., Ltd., Beijing, China; College of Public Health, Sichuan University, Chengdu, China; Guangdong Lewwin Pharmaceutical Research Institute Co. Ltd., Guangdong, China; Hunan Prima Drug Research Center Co., Ltd., Changsha, China; UCB, Braine l'Alleud, Belgium; Health and Environmental Sciences Institute (HESI), Washington, DC, United States of America; Cytokinetics LLC., South San Francisco, CA, United States of AmericaShow moreShow less
34
days
Weight of evidence in safety pharmacology guidance: A case for explicit probabilistic reasoning in the revision of ICH S7A
Authors
Derek J. Leishman; Michael K. Pugsley; Christopher P. Regan; Sridharan Rajamani; Michael G. Rolf; Eric I. Rossman; Jean-Pierre Valentin; Todd A. Wisialowski; Jill V. Nichols; Hugo M. VargasShow moreShow less
Affiliations
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United States of America; Cytokinetics, Toxicology & Safety Pharmacology, South San Francisco, CA, United States of America; Safety & Exploratory Pharmacology, Merck & Co., Inc., Rahway, NJ, United States of America; Johnson & Johnson Innovative Medicine, 3120 Merryfield Row, San Diego, CA 92121, United States of America; AstraZeneca R&D, Pepparedsleden 1, 431 83, Mölndal, Sweden; Labcorp Early Development Laboratories Inc., Madison, WI 53704, United States of America; Early Clinical Development & Translational Science, UCB, Braine-l'Alleud, Belgium; Pfizer Research and Development, Safety Pharmacology, Groton, CT 06340, United States of America; Amgen, Inc, Translational Safety & Risk Sciences, Thousand Oaks, CA, United States of AmericaShow moreShow less
219
days
Impact of filter selection on UPLC quantification of terbinafine hydrochloride: Optimization of sample preparation and method validation
Authors
Giovanna Pereira Peressoni; Nicolly Bittencourt Guedes; Izabelle Amorim Ferreira Boza; Giovana Carolina Bazzo; Hellen Karine StulzerShow moreShow less
Affiliations
Department of Chemistry, Center for Physical and Mathematical Sciences, Federal University of Santa Catarina, 88040-900 Florianópolis, SC, Brazil; Department of Pharmaceutical Sciences, Federal University of Santa Catarina, 88040-900 Florianópolis, SC, BrazilShow moreShow less
194
days
Development of spectroscopic methods using charge transfer complex for the quantitative estimation of proguanil hydrochloride: Insights from greenness evaluation, BSA binding, molecular docking, antimicrobial studies and Insilico toxicity assessment
Authors
Abdullah Mannan; Adila Khalil; Mohammad Kashif; Aliya FirdausShow moreShow less
Affiliations
Analytical Chemistry Section, Department of Chemistry, Aligarh Muslim University, Aligarh, (U.P.) 202002, India; Bio-control Research Laboratory, Integral University, Kursi Road, Lucknow, (U.P.) 226026, IndiaShow moreShow less
12
days
Advancing safety pharmacology: Emerging technologies, innovative methods, and future directions
Authors
Michael K. Pugsley; Brett R. Winters; Lutfiya Miller; Simon Authier; Michael J. CurtisShow moreShow less
Affiliations
Toxicology & Safety Pharmacology, Cytokinetics, South San Francisco, CA 94080, USA; 3rdAI LLC, Birmingham, AL, USA; Charles River Laboratories, Laval, QC H7V 4B3, Canada; Cardiovascular Division, King's College London, Rayne Institute, St Thomas' Hospital, London SE17EH, UKShow moreShow less
FAQ
How long does JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS take to review a manuscript?
As of 2026-11-19, CrushSCI has 14 complete review records for JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. The fastest paper went from submission to acceptance in 12 days (Advancing safety pharmacology: Emerging technologies, innovative methods, and future directions, received 2026-07-16, accepted 2026-07-28); the slowest took 219 days. The average is 117.1 days and the median is 127 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
